BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

BaroFold, Inc. Appoints J. William Freytag, Ph.D. as President and Chief Executive Officer


1/28/2009 6:18:12 AM

BOULDER, Colo.--(BUSINESS WIRE)--BaroFold, Inc., a biopharmaceutical company developing “BioBetter” protein therapeutics, announced today the appointment of J. William Freytag, Ph.D. as President and Chief Executive Officer.

“We are delighted to attract a leader with such an outstanding record of success,” stated Kyle Lefkoff, General Partner of Boulder Ventures and Chairman of BaroFold’s Board of Directors. “BaroFold is making excellent progress on the development of its pipeline of protein therapeutics, and Bill’s exceptional track record will help capitalize on our opportunity to make BaroFold a leading company in the fast emerging BioBetter protein therapeutic field.”

“I am truly excited to join such a talented team that has produced excellent progress exploiting its proprietary protein folding technology (PreEMT™) for the development of next generation follow-on protein therapeutics,” stated Dr. Freytag, CEO. “This dynamic company offers an exceptional opportunity to deliver improved and novel protein therapeutics.”

As BaroFold’s new President and CEO, Dr. Freytag brings more than 25 years of experience in the biotechnology and pharmaceutical industries. Most recently, Dr. Freytag served as Chairman and CEO of Aspreva Pharmaceuticals, Inc. from July 2007 until its merger with Galenica AG in January 2008. Previously, Dr. Freytag served as Chairman and CEO of Myogen, Inc. from July 1998 until it was acquired by Gilead Sciences, Inc. in November 2006. Prior to Myogen, Dr. Freytag held senior executive roles with Somatogen, Inc., a biopharmaceutical company where he was responsible for corporate and commercial development, and at Boehringer Mannheim Corporation, where he served as President of Research and Development. Dr. Freytag spent 10 years with DuPont Medical Products in various research and business positions. In addition to his role at BaroFold, Dr. Freytag currently serves as the chairman of the board for BiOptix LLC and is also serving on the Board of Directors of GlobeImmune, Inc., Sierra Neuropharmaceuticals, Inc., and ARCA Biopharma, Inc. He earned his Ph.D. in biochemistry from the University of Kansas Medical Center.

About BaroFold

BaroFold is developing improved and novel biopharmaceuticals targeting validated disease pathways with blockbuster potential utilizing its proprietary process technologies. www.barofold.com.

This press release contains forward-looking statements that involve risks and uncertainties, including statements relating to initiation and progress of the Company's clinical trial programs. Actual results could differ materially from those projected and the Company cautions investors not to place undue reliance on the forward-looking statements contained in this release.

Contact:

BaroFold, Inc. Julia Kendall, 303-545-0358 Business Communications Manager jkendall@barofold.com


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->